Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
Go back to Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study| (NASDAQ: KRYS) | Delayed: 346.39 -1.7 (0.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $348.09 | 52 Week High | $ | |||
| Open | $347.56 | 52 Week Low | $ | |||
| Day High | $349.66 | P/E | N/A | |||
| Day Low | $344.26 | EPS | $ | |||
| Volume | 16,993 | |||||

